The U.S. Food and Drug Administration revised the Emergency Use Authorization (EUA) for Paxlovid (nirmatrelvir and ritonavir), to authorize state-licensed pharmacists to prescribe Paxlovid to eligible patients, with certain limitations to ensure appropriate patient assessment and prescribing of Paxlovid.
Paxlovid is authorized for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms or about 88 pounds) with positive results of direct SARS-CoV-2 viral testing, who are at high risk for progression to severe COVID-19, including hospitalization or death. Patients in the authorized population who report a positive home test result from a rapid antigen diagnostic test, or a positive PCR test, to their provider are eligible for Paxlovid under the EUA.
“The FDA recognizes the important role pharmacists have played and continue to play in combatting this pandemic,” said Patrizia Cavazzoni, M.D., director for the FDA’s Center for Drug Evaluation and Research. “Since Paxlovid must be taken within five days after symptoms begin, authorizing state-licensed pharmacists to prescribe Paxlovid could expand access to timely treatment for some patients who are eligible to receive this drug for the treatment of COVID-19.”
At Skippack Pharmacy, we are a test-to-treat site and may be able to prescribe/dispense you Paxlovid with certain limitations.
In the event any of the following apply…you will need to seek guidance/a script from a physician, advanced practice registered nurse, or physician assistant licensed or authorized under state law to prescribe drugs:
- Sufficient information is not available to assess renal and hepatic function.
- Sufficient information is not available to assess for a potential drug interaction.
- Modification of other medications is needed due to a potential drug interaction.
- Paxlovid is not an appropriate therapeutic option based on the current Fact Sheet for Healthcare Providers or due to potential drug interactions for which recommended monitoring would not be feasible.
What is Paxlovid?
Paxlovid is used to treat mild-to-moderate COVID-19 in certain patients and consists of two drugs, nirmatrelvir and ritonavir. The two drugs should be taken together twice a day. If you do not have poor kidney function, you will take two nirmatrelvir (pink oval tablets) and one ritonavir (white or off-white tablet) together twice a day. If you have poor kidney function, you will take one nirmatrelvir (pink oval tablet) and one ritonavir (white or off-white tablet) together twice a day. Paxlovid is indicated for a 5 day treatment and should not be taken more than 5 consecutive days. If after 5 days, you do not feel better or feel worse, contact your healthcare provider.
How do I get Paxlovid?
Pharmacists are now able to prescribe Paxlovid. Please fill out our Paxlovid Eligibility Form to see if you are eligible to receive Paxlovid. After our team reviews your submission, we will let you know if you are eligible to receive Paxlovid through our pharmacy. Additionally, your doctor, physician assistant, or an advanced practice registered nurse can also prescribe Paxlovid for you – have them electronically send it or call it into Skippack Pharmacy. Once we have received
your prescription ready, we will prepare the RX and send you a text message to inform you it is ready. Thereafter, you or a designated family member/friend will be able to pick up your medication from our pharmacy from outside of the pharmacy (we request no one comes into the pharmacy who is COVID+ or been exposed to someone who is COVID+ and thus have contactless curb-side pick up available). Contactless delivery is available same-day within 5 miles at a charge of $5 or within 10 miles at a charge of $10.